Anzeige
Mehr »
Login
Montag, 21.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Endlich!!! Gold-Aktien explodieren! Jetzt die Chance auf riesige Gewinne nutzen – mit dieser Aktie!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
659 Leser
Artikel bewerten:
(2)

Publicis Groupe: PUBLICIS GROUPE TO ACQUIRE CITRUSAD TO LEAD THE NEW GENERATION OF IDENTITY-LED RETAIL MEDIA

PUBLICIS GROUPE TO ACQUIRE CITRUSAD TO LEAD THE NEW GENERATION OF IDENTITY-LED RETAIL MEDIA


Link to the Press release


PUBLICIS GROUPE TO ACQUIRE CITRUSAD
TO LEAD THE NEW GENERATION OF
IDENTITY-LED RETAIL MEDIA

CitrusAd is a SaaS platform optimizing brands marketing performance
directly within retailer websites

By combining CitrusAd with Epsilon's CORE ID, Publicis Groupe will create the industry's first global retail media offering based on real identity


Paris - July 15, 2021 - Publicis Groupe [Euronext Paris FR0000130577, CAC 40] today announces the acquisition of CitrusAd, a software as a service (SaaS) platform optimizing brands marketing performances directly within retailer websites. With more than 50% of its activities in the U.S., CitrusAd is present across 22 countries and 6 industries. CitrusAd provides its world-class technology to more than 70 major retailers globally and over 4,000 brands are utilizing their self-served platform.

In 2023, ecommerce sales for CPG brands will have doubled versus 2019 levels. In this context, retail media is undergoing exponential growth. From c. $30bn annually already, it is set to double in the next 5 years, and will represen t one of the biggest channels of CPG media spends in the next few year.

CitrusAd's onsite expertise complemented with Epsilon's offsite retail media offering, both powered by the CORE ID, uniquely positions Publicis Groupe to lead the new generation of identity-led retail media, with transparent measurement validated by transactions.

This will provide Publicis Groupe clients with three decisive competitive advantages in e-commerce:

  • Growth: Clients will be able to accelerate their growth in this dynamic channel, by increasing conversion rate and maximizing return on ad spends. CitrusAd's conversion rates are among the highest across the entire media industry with 60% conversion after a click.
  • Customer understanding: Brands will access superior customer understanding based on first-party data from retailers, equipping them for a cookieless world. Complementing CitrusAd with Epsilon's capabilities, Publicis will be able to deliver best in class identity resolution, with no dependency on third-party cookies, for optimized activation. All of this delivered in a totally consent-by-design and privacy-compliant way.
  • Consolidated measurement: Brands will be able to reach their customers both onsite (in retailer ecosystems) and offsite (in publisher ecosystems) and measure in real-time the consolidated performance of their media investments, whatever the channel of conversions: in-store or online. All of this at SKU level and validated directly by transactions.

CitrusAd is an Australian-based company founded in 2017 by Brad Moran and Nick Paech and gathers 130 engineers and retail media experts around the world. The company will act as a standalone business within Epsilon, being closely integrated into their technology to achieve market leading synergies. The transaction remains subject to customary approvals and is expected to close in the next weeks.

Brad Moran, Co-Founder and CEO of CitrusAd said: "It's not every day you find a partner the size of Publicis Groupe that not only shares the same vision and entrepreneurial spirit as CitrusAd but who can apply their advertising prowess and muscle to a technology company like ours. Retailers and brands are entering uncharted territory as retail media grows and having Publicis supporting CitrusAd in its efforts, I know that our customers will reap the benefit of a century's worth of media expertise combined with high quality technology and a team of retail media experts".

Arthur Sadoun, CEO and Chairman of Publicis Groupe said :"We are delighted to welcome Brad, Nick and the CitrusAd team to Publicis. The leading technology they have developed, coupled with Epsilon's CORE ID will enable CPG brands to grow faster and retailers to generate new sources of revenue to win in a platform world. It will also give to Publicis a strong competitive advantage in a channel that by 2025 should surpass traditional TV spend"

About Publicis Groupe - The Power of One
Publicis Groupe [Euronext Paris FR0000130577, CAC 40] is a global leader in communication. The Groupe is positioned at every step of the value chain, from consulting to execution, combining marketing transformation and digital business transformation. Publicis Groupe is a privileged partner in its clients' transformation to enhance personalization at scale. The Groupe relies on ten expertise concentrated within four main activities: Communication, Media, Data and Technology. Through a unified and fluid organization, its clients have a facilitated access to all its expertise in every market. Present in over 100 countries, Publicis Groupe employs around 80,000 professionals.
www.publicisgroupe.com | Twitter:@PublicisGroupe | Facebook | LinkedIn | YouTube | Viva la Difference!

About CitrusAd
CitrusAdis the world-leading, white-label, self-serve, ecommerce ad-serving platform that enables retailers to monetize their digital shelf-space while enabling brands to increase sales by launching targeted and cost-effective digital campaigns into retailer websites. Since it was launched in 2017, CitrusAd powers the fastest growing ecommerce ad network in the USA and has become the global, retail industry's preferred ad-serving platform, service and retail media sales organization. Successful retailers, in all verticals across 25 countries are leveraging the CitrusAd platform and real-time relevancy engine to create a more personalized shopping experience and deliver greater ROI for suppliers. For more information, visit https://www.citrusad.com



Contacts
Delphine Stricker
Alessandra Girolami
Corporate Communications
Investor Relations
+ 33 (0)6 38 81 40 00
+ 33 (0)1 44 43 77 88
delphine.stricker@publicisgroupe.com
alessandra.girolami@publicisgroupe.com
Brice Paris Investor Relations + 33 (0)1 44 43 79 26 brice.paris@publicisgroupe.com



© 2021 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.